Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Cristián Pereda"'
Autor:
María Alejandra Gleisner, Cristián Pereda, Andrés Tittarelli, Mariela Navarrete, Camila Fuentes, Ignacio Ávalos, Fabian Tempio, Juan Pablo Araya, María Inés Becker, Fermín Eduardo González, Mercedes Natalia López, Flavio Salazar-Onfray
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 2 (2020)
Background Immune checkpoint blocker (ICB) therapy has shown survival benefits for some patients with cancer. Nevertheless, many individuals remain refractory or acquire resistance to treatment, motivating the exploration of complementary immunothera
Externí odkaz:
https://doaj.org/article/28c908f8ce38455c8c9cfa54e97678c0
Autor:
Iván Flores, Daniel Hevia, Andrés Tittarelli, Dafne Soto, Daniel Rojas-Sepúlveda, Cristián Pereda, Fabián Tempio, Camila Fuentes, Cristian Falcón-Beas, Jimena Gatica, Felipe Falcón-Beas, Mario Galindo, Flavio Salazar-Onfray, Fermín E. González, Mercedes N. López
Publikováno v:
Journal of Immunology Research, Vol 2019 (2019)
Ovarian epithelial carcinoma (OEC) is the most frequent ovarian tumor, characterized by a high mortality in advanced stages where conventional therapies are not effective. Based on the role of the immune system in the progression of this disease, imm
Externí odkaz:
https://doaj.org/article/27606a5c810546ba836ac9c1fa8ce926
Autor:
Fermín E. González, Alexey Chernobrovkin, Cristián Pereda, Tamara García-Salum, Andrés Tittarelli, Mercedes N. López, Flavio Salazar-Onfray, Roman A. Zubarev
Publikováno v:
Journal of Immunology Research, Vol 2018 (2018)
Autologous dendritic cells (DCs) loaded with cancer cell-derived lysates have become a promising tool in cancer immunotherapy. During the last decade, we demonstrated that vaccination of advanced melanoma patients with autologous tumor antigen presen
Externí odkaz:
https://doaj.org/article/ef1825395fd746dcb5cfe14ad9714aa3
Publikováno v:
Biological Research, Vol 46, Iss 4, Pp 431-440 (2013)
Here we summarize 10 years of effort in the development of a biomedical innovation with global projections. This innovation consists of a novel method for the production of therapeutic dendritic-like cells called Tumor Antigen Presenting Cells (TAPCe
Externí odkaz:
https://doaj.org/article/f142821d88cd4d78bbb1aa6ad7bc665d
Autor:
Flavio Salazar-Onfray, Mercedes N. López, Paola Garrido, Carlos Ferrada, Ariadna Mendoza-Naranjo, Marcela Hermoso, Arturo Ferreira, Lorena Salazar, Tamara García, Daniel Hevia, Cristián Pereda, Diego Reyes, Marcos Ramírez, Fermín E. González, Andrés Tittarelli, Carlos Saffie, Raquel Aguilera
Supplementary Figures S1-S4; Supplementary Table S1.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5aec6165b161c04802a69917f02ebdcf
https://doi.org/10.1158/1078-0432.22442501
https://doi.org/10.1158/1078-0432.22442501
Autor:
Flavio Salazar-Onfray, Mercedes N. López, Paola Garrido, Carlos Ferrada, Ariadna Mendoza-Naranjo, Marcela Hermoso, Arturo Ferreira, Lorena Salazar, Tamara García, Daniel Hevia, Cristián Pereda, Diego Reyes, Marcos Ramírez, Fermín E. González, Andrés Tittarelli, Carlos Saffie, Raquel Aguilera
Purpose: This study characterizes, biologically and clinically, a novel type of dendritic cells (DC) produced in the short term and called tumor antigen–presenting cells (TAPCells). In particular, we identified factors present in a lysate derived f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6a57e54e0538b7abcda8e15e84522c4f
https://doi.org/10.1158/1078-0432.c.6519215
https://doi.org/10.1158/1078-0432.c.6519215
Autor:
Alfredo Torres, Sheilah Vivanco, Francisca Lavín, Cristián Pereda, Alexey Chernobrovkin, Alejandra Gleisner, Marcela Alcota, Milton Larrondo, Mercedes N. López, Flavio Salazar-Onfray, Roman A. Zubarev, Fermín E. González
Publikováno v:
International Journal of Molecular Sciences; Volume 23; Issue 13; Pages: 6882
Damage-associated molecular patterns (DAMPs) play a critical role in dendritic cells (DCs) ability to trigger a specific and efficient adaptive immune response for different physiological and pathological scenarios. We have previously identified cons
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::07e7dd1b6d5400d56fe00b939c1ff304
https://pubmed.ncbi.nlm.nih.gov/35805888
https://pubmed.ncbi.nlm.nih.gov/35805888
Autor:
Cristián Pereda, Fermín E. González, Fabian Tempio, Andrés Tittarelli, Jimena Gatica, Daniel Rojas-Sepúlveda, Mario Galindo, Mercedes N. López, Dafne Soto, Camila Fuentes, Felipe Falcón-Beas, Flavio Salazar-Onfray, Daniel Hevia, Iván Flores, Cristián Falcón-Beas
Publikováno v:
Journal of Immunology Research, Vol 2019 (2019)
Journal of Immunology Research
Journal of Immunology Research
Ovarian epithelial carcinoma (OEC) is the most frequent ovarian tumor, characterized by a high mortality in advanced stages where conventional therapies are not effective. Based on the role of the immune system in the progression of this disease, imm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f685536b849d833d2aa3844b00eda276
https://doi.org/10.1155/2019/9631515
https://doi.org/10.1155/2019/9631515
Autor:
Fermín E. González, Claudio A. Perez, Cristián Pereda, Felipe Falcón-Beas, Andrés Tittarelli, Mercedes N. López, Fabian Tempio, Cristián Falcón-Beas, Paola Garrido, Carolina Behrens, Gabriela Mora-Bau, Iván Flores, Daniel Hevia, Flavio Salazar-Onfray, Gabriel Ascui
Publikováno v:
Immunobiology. 224:697-705
Background Dendritic cells (DCs) are usually immunogenic, but they are also capable of inducing tolerance under anti-inflammatory conditions. Immunotherapy based on autologous DCs loaded with an allogeneic melanoma cell lysate (TRIMEL/DCs) induces im
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a0ec213f05361e97b03981ca0d86cdec
https://doi.org/10.1016/j.imbio.2019.05.011
https://doi.org/10.1016/j.imbio.2019.05.011
Autor:
Cristián Pereda, María Alejandra Gleisner, Fabian Tempio, Camila Fuentes, Flavio Salazar-Onfray, Juan Pablo Araya, Fermín E. González, María Inés Becker, Mariela Navarrete, Ignacio Ávalos, Mercedes N. López, Andrés Tittarelli
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 2 (2020)
Journal for Immunotherapy of Cancer
Journal for Immunotherapy of Cancer
BackgroundImmune checkpoint blocker (ICB) therapy has shown survival benefits for some patients with cancer. Nevertheless, many individuals remain refractory or acquire resistance to treatment, motivating the exploration of complementary immunotherap
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1e95bda8786c9353ff019c9f450f9c88
https://jitc.bmj.com/content/8/2/e000999.full
https://jitc.bmj.com/content/8/2/e000999.full